Skip to main content

H-CYTE, Inc. (HCYT)

OTCMKTS: HCYT · Delayed Price · USD
2.50
+0.05 (2.04%)
Jun 2, 2023 4:00 PM EDT - Market closed

H-CYTE Market Cap

H-CYTE has a market cap or net worth of $1.06 million as of June 5, 2023. Its market cap has decreased by -90.90% in one year.

Market Cap
1.06M
Enterprise Value
8.45M
1-Year Change
-90.90%
Ranking
n/a
Category
Nano-Cap
Stock Price
$2.50

Market Cap Chart

Since February 2, 2015, H-CYTE's market cap has decreased from $58.00M to $1.06M, a decrease of -98.18%. That is a compound annual growth rate of -41.68%.

History

DateMarket Cap% Change
Jul 7, 20221.00M-
Jul 6, 20221.00M-
Jul 5, 20221.00M
-80.39%
Jul 1, 20225.10M-
Jun 30, 20225.10M-
Jun 29, 20225.10M-
Jun 28, 20225.10M-
Jun 27, 20225.10M-
Jun 24, 20225.10M-
Jun 23, 20225.10M-
Jun 22, 20225.10M-
Jun 21, 20225.10M-
Jun 17, 20225.10M-
Jun 16, 20225.10M-
Jun 15, 20225.10M-
Jun 14, 20225.10M-
Jun 13, 20225.10M-
Jun 10, 20225.10M
6.25%
Jun 9, 20224.80M
-11.11%
Jun 8, 20225.40M-
Jun 7, 20225.40M-
Jun 6, 20225.40M-
Jun 3, 20225.40M
5.88%
Jun 2, 20225.10M
-5.56%
Jun 1, 20225.40M-
View and export this data all the way back to 2015. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Genelux Corporation 693.09M
GH Research PLC 623.21M
Aura Biosciences, Inc. 457.38M
Dyadic International, Inc. 67.71M
Axcella Health Inc. 26.91M
Monopar Therapeutics Inc. 13.09M
Cingulate Inc. 12.64M
Comera Life Sciences Holdings, Inc. 8.92M
AXIM Biotechnologies, Inc. 5.41M
Market Cap Rankings